$0.852000
-0.0070-0.81%
At Close: -
$0.880000
0.033.29%
After Hours: 5:44 PM EDT
15 minutes delayed
Comments
Loading...
Sonnet BioTherapeutics
SONNNASDAQ
Sonnet BioTherapeutics (NASDAQ:SONN) Stock, Earnings Estimates, EPS, And Revenue
Sonnet BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.760
Quarterly Revenue Estimate
$30K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$92.7K
Analyze the earnings history of Sonnet BioTherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -$2.86 | -$0.76 | — | — | $36.85K | $30.00K | — | — | 08/12/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$7.55 | $0.13 | $0.07 | -46.15% | $36.45K | $10.00K | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$17.60 | -$0.90 | -$0.31 | 65.56% | $37.26K | $20.00K | $18.63K | -6.87% | 02/14/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$36.52 | -$0.90 | -$0.78 | 13.33% | $62.75K | $20.00K | $37.26K | 86.27% | 12/14/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$40.04 | -$6.82 | -$2.86 | 5806.45% | $62.07K | — | $36.85K | — | 08/14/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$42.02 | — | -$7.48 | — | $95.32K | — | $36.45K | — | 05/10/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$30.80 | — | -$17.60 | — | $129.80K | — | $37.26K | — | 02/13/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$27.72 | — | -$36.52 | — | $0.00 | — | $62.75K | — | 12/15/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$83.16 | — | -$40.04 | — | $0.00 | — | $62.07K | — | 08/15/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$98.56 | — | -$43.12 | — | $0.00 | — | $95.32K | — | 05/10/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$104.72 | — | -$30.80 | — | $0.00 | — | $129.80K | — | 02/08/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$1.46K | — | -$27.72 | — | $0.00 | — | $0.00 | — | 12/17/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$135.52 | — | -$83.16 | — | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$15.40 | — | -$98.56 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$135.52 | — | -$104.72 | — | — | — | $0.00 | — | 02/16/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$1.46K | — | — | — | $0.00 | — | 12/17/2020 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$135.52 | — | — | — | $0.00 | — | 08/14/2020 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$15.40 | — | — | — | $0.00 | — | 05/18/2020 | Get Alert |
Sonnet BioTherapeutics (SONN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $0.07 | $0.13 | -46.2 % |
| Dec 2023 | 2024-02-14 | $-0.31 | $-0.90 | 65.6 % |
| Sep 2023 | 2023-12-14 | $-0.78 | $-0.90 | 13.3 % |
| Jun 2023 | 2023-08-14 | $-2.86 | $-6.82 | 5806.4 % |
Sonnet BioTherapeutics (SONN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $0 | $10.00K | -100.0 % |
| Dec 2023 | 2024-02-14 | $18.63K | $20.00K | -6.87 % |
| Sep 2023 | 2023-12-14 | $37.26K | $20.00K | 86.3 % |
FAQ
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics (SONN) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Sonnet BioTherapeutics (NASDAQ:SONN)?
The Actual EPS was $0.07, which missed the estimate of $0.13.
What were Sonnet BioTherapeutics’s (NASDAQ:SONN) revenues?
The Actual Revenue was $0K, which missed the estimate of $10K.
Browse earnings estimates, EPS, and revenue on all stocks.